In pharmacy news:

Pfizer, which is planning a $160-billion merger with Allergan to slash its U.S. taxes, raised U.S. prices for more than 100 of its drugs on January 1st, some by as much as 20 percent, according to analyses accessed by Reuters and confirmed by Pfizer. Among the relevant increases for workers’ comp payers are a 9.4 percent increase for the common pain drug Lyrica, which generated $2.3 billion in 2014 U.S. sales, and a 12.9 percent increase for erectile dysfunction drug Viagra (necessary as a complication of opioid therapy), which had 2014 U.S. sales of $1.1 billion.

Read further details from Reuters here.

Leave a Comment

Your email address will not be published. Required fields are marked *